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Abstract 
  
Rationale 
Regardless of health issue, health sector, patient condition or treatment modality, the chances 
DUHWKDWSURYLVLRQLVVXSSRUWHGE\µDJXLGHOLQH¶PDNLQJSURIHVVLRQDOO\-endorsed 
recommendations on best practice. Against this background, research has proliferated seeking 
to evaluate how effectively such guidance is followed.  These investigations paint a gloomy 
picture with many a guideline prompting lip-service, inattention and even opposition. This 
predicament has prompted a further literature on how to improve the uptake of guidelines and 
this paper considers how to draw together lessons from these inquiries.   
Methods  
This huge body of material presents a considerable challenge for research synthesis and this 
paper produces a critical, methodological comparison of two types of review attempting to 
meet that task. Firstly, it provides an overvieZRIWKHFXUUHQWRUWKRGR[\QDPHO\µWKHPDWLF
UHYLHZV¶ZKLFKDJJUHJDWHDQGHQXPHUDWHWKHbarriers and facilitators to guideline 
implementation. It then outlines a µrealist synthesis¶IRFXVVLQJRQWHVWLQJWKHprogramme 
theories that practitioners have devised to improve guideline uptake. 
Results 
Thematic reviews aim to provide a definitive, comprehensive catalogue of the facilitators and 
barriers to guideline implementation. As such they present a restatement of the underlying 
problems rather than an improvement strategy. The realist approach assumes that the 
incorporation of any guideline into current practice will produce unintended system strains as 
different stakeholders wrestle over responsibilities. These distortions will prompt 
supplementary revisions to guidelines, which in turn beget further strains. Realist reviews 
follow this dynamic understanding of organisational change. 
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Conclusions 
Healthcare decision makers operate in systems that are awash with guidelines. But guidelines 
only have paper authority.  Managers do not need a checklist of their pros and cons, because 
the fate of guidelines depends on their reception rather than their production. They do need 
decision support on how to engineer and re-engineer guidelines so they dovetail with 
evolving systems of healthcare delivery. 
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Introduction: the guidelines industry 
Guidelines are ubiquitous in healthcare; there are guidelines for every condition from 
abdominal pain to zoster virus. There are guidelines for all sectors: clinical practice 
guidelines, public health guidelines, technology appraisal guidelines, self-care guidelines. 
There are guidelines for every point in the patient pathway: diagnosis, screening, referral, 
treatment, withdrawal-from-treatment. Production takes place at every level from cottage 
industry (e.g. guidelines for local practices and emergency teams) to national function (e.g. 
guidelines issued by Royal Colleges and National Institutes) to global enterprise (e.g. 
guidelines from WHO taskforces). The delivery formats are diverse, covering everything 
from the one-page poster to hundred-page manuals and, latterly, to e-guidelines. Guidelines 
are so pivotal that they are now under constant formal pressure to meet agreed quality 
standards for their development and dissemination [1,2]. 
Whilst the production of  guidelines is seemingly relentless, it turns out that guideline 
µcompliance¶E\SUDFWLWLRQHUVRQWKHJURXQG is varied; many would say suboptimal [3-5]. The 
associated misgiving is that the evidence base,  of which the guidance is supposedly the 
repository, may not be used to the full. The response from the research community to this has 
been immediate and proliILF0DQ\KXQGUHGVRIVWXGLHVKDYHDPDVVHGDVVHVVLQJJXLGHOLQHµ;¶
in order to discover the extent of compliance by practitioners and the reasons why the advice 
is and is not followed. Investigation on this scale results inevitably in the need for synthesis 
DQGVRWKHSULPDU\UHVHDUFKLVUDSLGO\IROORZHGE\V\VWHPDWLFUHYLHZVRIJXLGHOLQHVIURPµ$
WR=¶- trying to understand, in broader terms, what works in guideline production and to 
unearth the all-pervasive facilitators and impediments to their implementation. This brings us 
to the methodological issue for the paper. How should such reviews be conducted so as to 
offer practical advice ± for both the intended recipients of guidelines (for example, 
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practitioners) and those with an interest in whether they are followed (for example, managers, 
commissioner and policy makers)?  
 
Approaches to review 
Traditional systematic reviews in the Cochrane tradition have revealed considerable 
variation in the extent to which stakeholders follow guidelines [6,7].  Attention has now 
turned to understanding why such variation exists and to explain why some guidelines are 
followed and others are not.  We compare and contrast two models of review as applied to 
these questions.  Firstly, we offer an overview of the mainstream method in this area ±
reviews that conceptualise the challenge of increasing the uptake of clinical guidelines as one 
of overcoming µEDUULHUV¶ and SURYLGLQJµIDFLOLWDWRUV¶[8,9]. We then go on to detail some work 
which considers that healthcare guidelines are always inserted into complex adaptive systems  
[10-13]ZKHUHERWKµEDUULHUV¶DQGµIDFLOLWDWRUV¶LQWHUORFNLQLQWULFDWHDQGFRQYROXWHGZD\V 
We then trace the challenges this creates in the system using the method of realist synthesis 
[14] and here we call on some material from a realist review [15]. 
Approach one: Thematic reviews ± facilitators and barriers to guidelines 
  The approach to research review considered here, which is sometimes characterised 
as a µthematic¶ RUµQDUUDWLYH¶SHUVSHFWLYHFDQ be considered the orthodox approach to 
research synthesis in the particular domain of guideline investigation. This approach to 
review seems particularly apposite because it builds directly on the raw materials available in 
the primary literature. Much of the basic research, on which such reviews are built, operates 
in the self-VW\OHGµEDUULHUVDQGIDFLOLWDWRUV¶DSSURDFK. It may be summarised as follows: a 
particular guideline is chosen for investigation as is a selected set of its intended users, most 
often practitioners. They are then faced with a broad set of questions on their familiarly with, 
6 
 
experience of, attitude toward, and confidence in the said guideline.  These responses are then 
subjected to thematic analysis.  
The primary analysis is usually presented in the form of a framework or typology. If 
VXUPRXQWHGWKHH[WUDFWHGWKHPHVEHFRPHµIDFLOLWDWRUV¶LIWKH\SUHVHQWDVWXPEOLQJEORFNWR
LPSOHPHQWDWLRQWKH\EHFDPHµEDUULHUV¶$OWKRXJKWKH\KDYHWKLVFRPPRQRULJLQWKHHQVXLQJ
frameworks vary greatly in the pattern of types and sub-types derived in the analysis. We 
present a brief synopsis from four characteristic studies in table 1 [16-19]. We have no space 
here to describe the eventuating themes in any detail ± hopefully their meaning will be 
reasonably self-evident from the chosen labels. In the original studies the meaning, 
distinguishing features and rationale for each type is elucidated in greater depth. Illustrative 
quotations are provided in the exposition of each theme. In respect of a widely cited theme on 
WKHQHHGIRUµFODULW\¶LQJXLGHOLQHSUHVHQWDWLRQD*3reportsµDFRPSOLFDWHGSLHFHRISDSHU
LW¶VQRXVHWRPH,¶PDVLPSOHPDQDQG,QHHGWRKDYHVLPSOHLGHDV¶ [18]. On the idea that 
µSDWLHQWSUHVVXUH¶ is a barrier, which may encourage the physician to ignore guidelines, 
another GP explains that radiography referrals for back pain are in high demand as a source 
RIµLOOQHVVOHJLWLPDWLRQ¶µ7KHSDWLHQWFDQFRPHKRPHDQGVD\³,KDGDQ;-UD\´DQGWKHQ
everybody will realiVH,KDYHDSDLQLQP\EDFN¶ [16].    Because they represent the daily 
struggles of actual users, these primary studies present rich practical insight of fortunes and 
foibles of guideline implementation.  
Table 1 about here [16-19] 
  
Here then are the bountiful raw materials for the thematic review, one that will go on 
to compile, reconcile and synthesise the fragmentary, local depictions of barriers and 
facilitators. There have been a number of such reviews from 1999 [20] to 2015 [21]. Here we 
provide an account of two of the most influential thematic reviews attempting to synthesis the 
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entire barriers and facilitators literature in relation to guideline use [8,9]. The research 
strategy is complex; it is a cross between a systematic review (scoping and definitional work, 
searching for studies, quality appraising, extracting findings) and a thematic analysis (to be 
precise a secondary thematic analysis of the various primary thematic analyses). The essential 
aim is to provide a master or meta-framework or hierarchical explanatory narrative that 
captures and combines all H[LVWLQJIUDPHZRUNV&RFKUDQHHWDOFDOOWKHPµEDUULHUJURXSLQJV¶
(Table 2) [9]. Gagliardi et al. FDOOLWDµILQDOFRQFHSWXDOIUDPHZRUN¶7DEOH[8]. Table 2 
contains somHDGGLWLRQDOLQIRUPDWLRQRQµIUHTXHQF\¶WKDWLVWKHQXPEHURIWLPHVDSDUWLFXODU
theme has been discovered in the primary literature. Table 3 provides a different set of 
themes and subthemes but also includes a useful third column providing brief examples 
explaining the coverage of each theme.  
Table 2 about here [9]  
Table 3 about here [8]  
 
What is evident when comparing these meta-frameworks is that although there are 
similarities between them, there are also significant differences. The results from other 
reviews in the barriers/facilitators tradition also offer no definitive framework. If we are 
looking for practical guidance, how should one chose between frameworks?  
 
There is, of course a large methodological literature on frameworks, classification 
systems, typologies, taxonomies, and so forth [22]. And within this there is the classic 
discussion on the different W\SHVRIµYDOLGLW\¶± µIDFH¶µFRQWHQW¶µFULWHULRQ¶µFRQVWUXFW¶DQG
so forth. All of the frameworks under discussion (primary and secondary) have evident face 
validity. They originate in the lived experience of guideline users - so that notion is no help in 
deciding between them. Most methodological authorities place IDLWKLQµFRQVWUXFWYDOLGLW\¶; 
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namely, that the worth of a measure is the degree to which it measures what it claims to 
measure. If one tests a theory using a particular measure and that theory is corroborated then 
this also adds validity to the measure. A measure becomes validated over time ± the more 
theories it supports and the more those theories are successful, the stronger the faith in the 
PHDVXUHµThe best construct is the one around which we can build the greatest number of 
LQIHUHQFHVLQWKHPRVWGLUHFWIDVKLRQ¶ [23].  
 
If one follows this advice (and we do) this allocates the assessment of the validity of 
any guidance framework to the utility of the model rather than the construction of the model. 
And this returns us to the central question of the paper ± how are users supposed to apply all 
of this evidence on guideline effectiveness? We begin by considering the expectations on this 
VFRUHRIRQHRXUUHYLHZWHDPV,QWKHVHFRQGKDOIRI*DJOLDUGLHWDO¶VSDSHUWKHUHLVDµWHVW¶RI
20 existing specialist guidelines WRVHHLIWKH\ILWZLWKWKHµH[WHQGHGPRGHO¶HPHUJLQJIURP
their typological review. Results are disappointing. The various guidelines under scrutiny are 
DGHTXDWHLQWHUPVRISUHVHQWLQJµJUDGHGHYLGHQFH¶EXWIHZH[DPSOHVFRQWDLQHGµDGGLWLRQDO
IHDWXUHVWKDWFRXOGLPSURYHJXLGHOLQHXVDJH¶ [8]. In short, most existing guidelines fare much 
better in their coverage of items in the upper sections of Table 3.  
 
A curiously limited notion of guideline validity is implied in this test. What the 
Gagliardi review seeks to inform is the business of guideline construction. The evidence on 
why potential users of guidelines follow or fail to follow them is returned on itself in order to 
improve the presentation and content of guidelines. A comprehensive, master framework is 
devised in the expectation that future guidelines should conform to that rubric. A grammatical 
shift from noun to adjective is introduced to establish this goal ± guidelines vary in their 
µLPSOHPHQWDELOW\¶and this evidence-endorsed template will help to get their content right. 
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The guideline industry is certainly promulgated and perhaps regulated as a result of such 
IUDPHZRUNV3RZHUIXOFROODERUDWLRQVKDYHJDWKHUHGSURPRWLQJWKHVHµLQWHUQDWLRQDOWRROVIRU
WKHUDWLQJDQGDVVHVVPHQWRISUDFWLFHJXLGHOLQHV¶such as the AGREE template 
(www.agreetrust.org/). 
 
But all this is indeed a curious interpretation of construct validity and guideline utility 
EHFDXVHWKHPDLQHPSLULFDOOHVVRQIURPWKHµEDUULHUVDQGIDFLOLWDWRUV¶ investigations is that 
guidelines only have paper authority. The reason why guidelines fail is little to do with their 
content and format (their implementabilty) but mostly due to complex decision structures in 
which they are embedded (their implementation). However perfect their presentation, 
however comprehensive their coverage, however true to template, there is no reason to 
suppose that guidelines will be followed. This is the lesson that emerges from all empirical 
studies. What matters is the reception that awaits guidance when it has left the page and 
enters the clinic.  
 
This brings us to a second and perhaps more commonplace expectation about how the 
thematic analysis on guideline effectiveness might be put to use. In this version, also evident 
in more recent endeavours [21], the review is said to provide an authoritative checklist of 
EDUULHUVIDFLOLWDWRUVWRJXLGHOLQHLPSOHPHQWDWLRQLQH[SHFWDWLRQWKDWLWSUHVHQWVDµWRGR¶OLVW
for policy-makers, managers and practitioners. The role of barrier and facilitator reviews, on 
this view, is to provide strategic overviews; they are the design tools itemizing what is 
required in a comprehensive planning process. On this view, it is up to decision makers to 
promote the deeds to ensure that the words of guidance are followed and, accordingly, the 
test of research utilisation is changed ± can it be said that barrier and facilitator classifications 
are an effective planning tool?  
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This checklist perspective has come in for its fair share of criticism, most notably in 
an article with a telling title: ,VWKHPHWDSKRURIµEDUULHUVWRFKDQJH¶XVHIXOLQXQGHUVWDQGLQJ
implementation? [24] This paper takes us back to the raw materials similar to those noted in 
many of the primary studies on guidelines. Prompted by questions about why guidance might 
be ignored, a GP in this VWXG\UHSOLHVµ%XWLIDQ\ERG\WKLQNVWKDWWKLQJVDUULYHKHUH
somebody has the time to look at it and then spread it as useful information that everybody 
else thinks sensibly about, thH\¶YHJRWDQRWKHUWKLQJFRPLQJ¶1RZµUHPRYLQJ¶WKLVEDUULHUWR
change is usually discussed in terms of simplifying guideline presentation, providing 
guideline summaries, improving the channelling of recommendations and so on, in order to 
make the guidelines easier to access and understand. The authors, however, submit the rival 
LQWHUSUHWDWLRQWKDWWKHµWLPHSUHVVXUHEDUULHU¶LVVLPSO\DQXQGHUO\LQJRUJDQLVDWLRQDOUHDOLW\
and that source of the problem and its solution may lay there [24].  
 
The point made here is that barriers are not something to be ticked off and torn down 
RQHDWDWLPH:KDWWKHµEDUULHUV¶SULPDU\VWXGLHVDUHDFWXDOO\GHVFULELQJDUHSHUVRQDOVRFLDO
and institutional interrelationships. Barriers interlock because a change in one part of a 
complex system will always trigger change in another and then another [13]. This suggests a 
rather different role for reviews of guideline uptake and compliance. What the synthesis 
should be studying and explaining is why some barriers are more intractable than others and 
why solutions always have emergent effects. Solving barrier A might exacerbate barrier B, 
solving barrier C might create unintended consequence D, introducing facilitator E might be 
crushed by impediment F.  We rather suppose that practitioners in the real world are faced 
with multiple and often competing system strains when contemplating the use of guidelines 
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and suggest that for reviews to be of practical use they need to capture this complexity. We 
turn next to a review attempting to decipher these interconnections. 
Approach Two: Complex adaptive systems and realist, programme theory approaches  
We devote the remainder of the paper to illustrating the potential of an alternative 
method for reviewing the primary research on guideline use and adherence in clinical 
practice. Realist synthesis promotes an explanatory role for systematic review and seeks to 
explain why an intervention might work (or flounder) and to uncover the many contingencies 
that generate success (or failure) [25]. The approach assumes heterogeneity in the 
implementation of and response to any intervention and seeks transferable lessons by 
focussing the review on µprogramme theories¶ which are common to all. Programme theories 
represent the ideas and assumptions underlying how and why an intervention is expected to 
work. A wider range of evidence may be drawn into the review, explored in a research design 
which extract, formalise and test the programme theories that lie beneath interventions. We 
concentrate this account entirely on the analytic structure, with the idea of using a review to 
explore programme theory. Further methodological details of other features of realist 
synthesis may be found in elsewhere [14,26].  
So what are the relevant programme theories that might underpin efforts to increase 
the utilisation of healthcare guidelines? We take a fresh point of departure drawn from 
complexity theory as it has been applied to understanding organisational change [11,27,28]. 
All healthcare organisations consist of different divisions, sections and departments. Each of 
these separate units deal with specialist tasks but for these functions to be fulfilled requires 
the sharing and harmonisation of goals. Healthcare organisations are also made up by staff 
and professional groups working in them as well as the people being served by them, each 
with their own aspirations and goals. Moreover, all healthcare organisations are located in a 
web of managerial, funding and political relations, which shape the provision on offer. 
12 
 
Together this medley of functions, competences, mental models and institutional constraints 
JHQHUDWHZKDW=LPPHUPDQHWDOFDOOµVWUXFWXUDOFRPSOH[LW\¶ [29]. Tensions, conflicts 
and turbulence can exist between these various layers, especially during innovation such as 
with the introduction of guidelines.  
The fate of any reform thus depends on its reception across all of these fronts. An 
intervention aimed at a particular function will reverberate across the whole system. 
Innovation is always accompanied by unpredictability and unintended consequences, by 
positive and negative feedback loops. On this model, whether by primary evaluation or 
systemic review, it is the task of research to trace and explain such emergent effects.  
The realist approach attempts to capture this dynamic using the idea that programme 
theories are under constant revision, in response to experience of implementing the 
intervention on the ground. A problem in healthcare delivery is recognised, an idea is devised 
that might deal with it, which is realised in a particular intervention, the intervention makes 
some headway but is thwarted at different points in the system, these strains generate further 
ideas to resolve them, they too are embodied in a revised programme, which makes partial 
progress but comes under new strains. And so the process continues. This style of 
management and policy making, uncharitably known as µmuddling through¶ [30], is exactly 
how interventions unfold. 
This then is the overall framework that we applied in our review of the uptake of 
guidelines.  Our mental image of the practitioner is not one of the master-planner, designing a 
guideline blueprint from scratch, rather it is of the manager or clinician coping with many 
existing guidance systems and attempting to integrate them into wider care regimes.  Indeed, 
we recognise that managers and clinicians may have diverse responses to guidelines, due to 
their different roles within health care organisations and spheres of influence. Our strategy 
was to search the primary literature for evidence of the system strains that develop on the 
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introduction of guidelines, to follow the revisions in programme theory that ensue and to 
attempt to chart the relative effectiveness of each twist and turn. Thus, realist synthesis 
locates primary studies to explore the form and direction of this continual process of theory 
refinement, in order to understand in what circumstances and through what processes these 
system strains are resolved.  Our aim here is not to offer the definitive answer as to why 
guidelines are or are not followed but to illustrate some of the contradictions between the 
different ideas put forward to improve the uptake of guidelines and explore whether and how 
they might be resolved. Our analytic strategy, on which we concentrate here, began with the 
identification of major system strains that have routinely occurred with the inception of 
guidelines and then went on to locate the evidence on the manner and the extent to which 
they could be overcome.  Major dilemmas that confront guideline use include: 
1. The tension in using the simple guidelines for complex comorbidity. 
2. The tension between (inter)national credibility of and local control over guidelines  
3. The tension between patient choice and top-down guidelines. 
4. The tension resulting from guideline oversupply ± a new guideline can swamp routine 
systems.  
We recognise that these are not definitive but are confident that they will be familiar to both 
managers and practitioners. What follows are some indicative data from the full review [15]; 
here we cover only the first two tensions and we extract only a few key findings in order to 
discuss their implications.  
System Strain 1: Simple Guidelines versus Co-morbid Patients 
A recurrent idea in all the aforementioned research is that guidelines are more likely 
to be implemented if the presentational format is straightforward, intelligible, 
comprehensible, uncomplicated and so on. The beginnings of a system strain emerge when 
through the surgery door walks patient X whose ills are far from uncomplicated. Several 
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studies have explored the problems of µfitting¶ the patient to the guideline when that patient 
has co-morbidities and, more especially, if that patient happens to be frail or elderly [31,32]. 
These studies exhibit the constant adjustment of programme theories that we elucidated 
earlier. 
We began our review by searching for background material that exemplified and 
charted this system strain.  We identified a number of studies that examined the texts of 
existing guidelines within a clinical domain and assessed the extent to which they dealt with 
co-morbidity.  Several of these studies have found that guidelines for a range of chronic 
FRQGLWLRQVµLQFRQVLVWHQWO\¶DWEHVWDQGµUDUHO\¶DWZRUst provided treatment recommendations 
for patients with multiple co-morbidities [33-38].  The quotations below illustrate the typical 
findings of these studies: 
 µ+DOIWKHJXLGHOLQHVDGGUHVVHGWUHDWPHQWIRUROGHUSDWLHQWVRUIRUSDWLHQWVZLWKRQH
comorbid condition. But only one addressed treatment for older patients with comorbid 
FRQGLWLRQV¶[38]. 
µ2IWKHJXLGHOLQHVDGGUHVVHGWKHLVVXHRIFRPRUELGLW\DQG
provided specific recommendations on comorbidity. In general, the guidelines included few 
recommendations on patients with comorbidity (mean 3 recommendations per guideline). Of 
the 59 comorbidity-related recommendations provided, 46 (78%) addressed concordant 
comorbidities, 8 (14%) discordant comorbidities, and for 5 (8%) the type of comorbidity was 
QRWVSHFLILHG¶[36]. 
Furthermore, one study found that the quality of the guidelines for dementia, as 
judged by an internationally agreed measurement of guideline quality, the AGREE tool, bore 
no relationship to the extent to which a guideline was relevant to older people with multi 
morbidity [33]7KLVVXJJHVWVWKDWFXUUHQWFRQFHSWXDOLVDWLRQVRIJXLGHOLQHµTXDOLW\¶GRQRW
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incorporate assessments of the external validity of such guidelines and their applicability to 
people with multiple co-morbid conditions. 
A basic tension, that current guidelines do not adequately address co-morbidity, is 
thus recognised in the literature. Our synthesis then explored a number of proposed solutions 
to this problem to examine the extent to which they do, in fact, resolve this tension.   We 
expressed these as different adaptations to the programme theory (simple guidelines are 
easier to follow) which attempt to incorporate advice on co-morbidity. We begin with the 
simplest adaptation, theory 1a, that one way of resolving the tension between the need for 
simple guidelines and the issue of co-morbidity is WRLQFUHDVHWKHFRPRUELGSDWLHQW¶VH[SRVXUH
to multiple guidelines. Several studies cover the potential costs and unintended conflicts of 
following more than one guideline simultaneously. One study used treatment dispensing data 
to show that 16% of people with diabetes being treated for other conditions received 
medicine with adverse effects on diabetes [39]. In another study, a panel of experts identified 
the possible serious drug-drug interactions in NICE guidelines for heart failure, type 2 
diabetes and depression in relation to guidelines for nine other potential co-morbid conditions 
and found 133 potential drug-drug interactions in the type 2 diabetes guidelines, 89 for 
depression and 111 for heart failure [40]. A further study mounted a simulation exercise on 
the consequences of following the explicit recommendations of two or more guidelines 
demonstrating a significant hike in the treatment burden, especially on self-care regimes in an 
elderly comorbid population ill equipped to meet such demands [35]. Another, earlier 
simulation study followed a hypothetical comorbid patient who, following all relevant 
guidelines, would be prescribed 12 medications at a cost of $406 per month, some with 
possible adverse effects [41]. This limited selection of the studies provides a fair indication of 
the fate of theory 1a - that expectations about the simultaneous use of multiple guidelines 
may exacerbate rather that solve the co-morbidity problem. 
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Lack of headway on this front leads, as ever, to more imaginative attempts to solve 
the impasse. We turn to the next adaptation, theory 1b, namely to increase attention to 
comorbidity within condition specific guidelines [36,37,42,43]. Here, the idea is that 
guidelines should provide information to enable clinicians to more effectively apply the 
guideline to patients with multi-morbidity; for example, by detailing the percentage of 
patients with co-morbid conditions included in the original trials and the extent to which co-
morbid conditions may modify treatment effects. However, most clinical trials are designed 
to obtain estimates of the maximum possible treatment effect of a drug in a single disease, 
rather than maximise the triaO¶V applicability to different groups of patients [44,45].  
This creates a further strain which is unlikely to be resolved as the evidence base on 
which guidelines are built privileges clinical trials, from which patients with multiple 
morbidities are generally excluded [45-48].  For example, Boyd et al (2012) reviewed 161 
trials on the Cochrane register evaluating drug and non-drug treatments for four common 
chronic conditions. They found that trials commonly excluded patients with co-morbidities; 
less than half of trials (43.5%) reported the prevalence of co-morbidities among participants 
with the index condition in their findings and only 3.1% of examined the extent to which co-
morbidities were an effect modifier on the overall treatment effect [44]. Fried et al (2014) 
conducted a systematic review of studies that examined outcomes of treatment for an index 
condition, or the outcomes of different treatment intensities of an index condition in the 
presence or absence of co-morbidity.  From 3252 potentially relevant papers, they identified 
only 45 studies which had conducted these analyses, with only one examining the effect of 
co-morbidity per se; most studies examined the effects of treating an index condition in the 
presence or absence of a single co-morbid condition [49].   This indicates that providing more 
detailed information on the relevance of the guidelines to patients with co-morbidities may 
stumble through a lack of such information.  It also sends us full circle to the original 
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conundrum ± addressing comorbidity within a guideline would inevitably increase the 
complexity of guidelines, which is already an established standard deterrent to their usage 
[50].  
(YHQWKHVHVLPSOHµQXJJHWVRIHYLGHQFH¶ show that guidelines are constantly being 
made and remade under this system strain. A further recent refinement, theory 1c, to 
guideline logic suggests a shift from µdisease specific JXLGHOLQHV¶ to µpatient centred 
guidelines¶[51-53]. To be more precise, such guidance intends to focus on subgroups, for 
example ± µGHFLVLRQPDNLQJRQFDUHRIWKHHOGHUO\ZLWKFRQGLWLRQV;C<DQG=¶*XLGHOLQHV
under this theory, should focus much more on choosing and prioritising treatment and so in 
theory reduce the tension inherent in following multiple combinations of condition specific 
guidance.  To work in practice, this theory rests on the idea that clinicians can take account of 
multiple patient factors in adjusting guideline recommendations to the patient in front of 
tKHP)RUH[DPSOH'XUVRUHFRPPHQGVWKDWFOLQLFLDQVVKRXOGµ(VWLPDWHWKHSDWLHQW¶V
approximate life expectancy compared to the median for individuals of that age-sex cohort by 
considering the presence or absence of unusually good or poor health and fXQFWLRQ¶[53]. 
There is already a problem with physicians being bombarded with guidelines on X, Y, Z. If 
thanks to patient complexity these become subdivided into guideline X1, X2, Y1, Y2, Y3, 
Z1, Z2, with supplementary decision rules on navigating to the appropriate pathway, there is 
an obvious emergent further problem afoot in the realm of guidance fatigue [54]. 
This seemingly insurmountable system tension has led to the advocacy of so called 
µUHDOHYLGHQFHEDVHGPHGLFLQH¶ZKLFKZHODEHOKHUHDV7KHRU\G$NH\FRPSRQHQWRI
µUHDOHYLGHQFHEDVHGPHGLFLQH¶LVWKDWKHDOWKSURIHVVLRQDOVWKURXJKGLVFXVVLRQZLWKSatients, 
integrate guidelines with patient values and clinical judgement to deliver personalised care to 
individual patients [55-57].   There is some evidence to suggest that this is how GPs on the 
ground operate when faced with clinical guidelines that fail to address multi-morbidity.  For 
18 
 
H[DPSOHTXDOLWDWLYHVWXGLHVRI*3V¶PDQDJHPHQWRISDWLHQWVZLWKPXWL-morbidity  indicate 
WKH\UHO\RQWKHLUFOLQLFDOMXGJHPHQWRUµFRPPRQVHQVH¶LQWKHIDFHRIFOLQLFDOJXLGHOLQHVDQG
adapted and prioritised their managHPHQWRISDWLHQWVSUREOHPVLQUHVSRQVHWRSDWLHQWV¶YDOXHV
and preferences [32,58-60].  However, in a context where the expectation is that guidelines 
should be followed as best practice, clinicians expressed some reservations about relying on 
RQH¶VFRPPRQ VHQVHEHFDXVHLWµZDVQRWFRQVLGHUHGDFFHSWDEOHDQ\PRUH¶>@ 
Thus, we complete our journey through this highly emergent and intractable system 
strain by concluding that clinician judgement and discretion are essential to patient care and 
thus also need to be understood in future advice on the implementation of guidelines. The 
evidence tells us that the tension between the need for simplicity in guidelines and the 
problem of multi-morbidity cannot be resolved. Perhaps, therefore, what is required  is a 
UHIUDPLQJRIWKHLVVXHIURPRQHRIDµODFNRIFRPSOLDQFH¶WRµFRQVLGHUHGDQGUDWLRQDO
UHMHFWLRQ¶RIJXLGHOLQHVLQVSHFLILFVLWXDWLRQVVXFKDVSDWLHQWVZLWKPXOWL-moribidity.  This 
conjecture, of course, requires further testing and analysis. 
System Strain 2: The tension between (inter)national credibility and local control over 
guidelines 
We now turn to our second system strain and again we chart the iterative process of 
theory refinement using a realist approach. As noted in Tables 1 and 2, the µcredibility¶ of 
guidelines is often cited as a key facilitator in influencing their uptake. Credibility, however, 
may be nurtured in quite different quarters and we use the review to uncover and test out a 
variety of programme theories attempting to decipher the key axis of credibility. As 
previously, we encounter a range of competing ideas (labelled 2a, 2b, 2c, etc) and we assess 
the available evidence that has accrued in support of each.  
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One assumption, theory 2a, begins with the notion that guideline development 
requires major clinical expertise and methodological resources. Accordingly, guidelines 
endorsed by national or global professional organisations are seen as more trustworthy and 
are, in turn, more likely to be implemented (e.g. The Royal College of Physicians National 
Clinical Guideline for Stroke). However, nationally developed guidelines may lack 
applicability and relevance to local contextual factors. A rival contention,  theory 2b,  posits 
that involving local practitioners is the key source of credibility because the guidance will 
include intelligence on the prevalence of the condition in the local community, the local 
availability of services and resources, and on current inter and intra organisational 
relationships (e.g. Oxfordshire Regional Genetics Service Referral Guidelines).  
Here we have the beginnings of a classic system strain, sometimes termed the 
µJORFDOLVP¶SDUDGR[7RDGGUHVVWKLVWHQVLRQ theory 2c, the local adaptation of nationally 
developed guidelines has been widely advocated as a potential solution. This proposition 
VHHNVDµEHVWRIERWKZRUOGV¶VROXWLRQDQGFRQVLGHUDEOHUHVRXUFHVKDYHEHHQH[SHQGHGLQ
pursuing it. The best known of these initiatives is the international ADAPTE collaboration 
(www.adapte.org). Under this regime, tKHWDVNRIµFXVWRPLVLQJ¶DJXLGHOLQHVRWKDWWKHJOREDO
becomes the local is itself a feat of organisation. Decisions need to be made about topics, 
organizing committees, source documentation, consultation rules, format and promotion. The 
ADAPTE process has a whole series of phases and modules, numbering 24 steps in all [61]. 
At the other end of the scale, adaptation can be ad hoc, locally initiated and focussed on 
particular units with identifiable users [62]. 
Whilst all this is proof positive for our thesis that reviewers of the guidelines literature 
must anticipate a moving target, it opens up another system tension in need of explanatory 
synthesis. How does the evidence stack up in relation to theory 2c ± does the local adaptation 
of guidelines make their content more relevant to local users and thus increase their use? 
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There is copious material comparing guideline content before and after adaptation. Some of 
this considers the extent to which adapted guidelines can be of the same standard as those 
with a national pedigree. Rowe, for instance, suggests that locally developed guidelines are 
poor in coverage according to AGREE standards [63]. By contrast, other inquiries suggest 
that the process of local adaptation does not seriously distort the clinical validity of the 
original guideline [64]. Further studies have attempted to adjudicate this debate and seek to 
unearth subtle, qualitative differences between the national and local instruments. Sometimes, 
the adapted guidelines have almost identical coverage and content as the originals [65]. Yet 
other research notes the adaptations are significant: specialising in topics with local priorities 
[64], having shorter and more accessible formats [64,66,67], and perhaps most significantly, 
providing additional information on the availability of local services and thresholds for 
referral [66]. In terms of guideline content, it is probably fair to say that the jury is still out on 
whether the local adaptation of national guidelines makes for significant change. Much 
GHSHQGVRQWKHFRQGLWLRQXQGHUVFUXWLQ\DQGWKHPRWLYDWLRQRIWKHµWUDQVODWRUV¶ 
Another relevant body of evidence here, uVXDOO\LQWKHJXLVHRIµproFHVVHYDOXDWLRQV¶
comes from studies which trace the practical steps and resources involved in guideline 
adaptation. Sometimes guidelines are adapted through a series of short workshops or 
meetings with local primary and secondary care clinicians [64-67]. For example, one study 
reports on a process that took two months from initiation to completion [62]. Another study 
reports a case where the adaptation was undertaken through twelve hours of group discussion 
[67]. By contrast, other studies have followed the processes involved using formal templates, 
such as ADAPTE described above, which attempt to standardise the process of guideline 
adaptation [68,69]. Key evidence emerging here suggests that full-blown formal adaptation is 
a resource intensive and costly business ± involving a need to revisit the original evidence, 
identifying additional research evidence to support local content, and providing 
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methodological support to critically appraise the final product [70] Process studies, in 
summary, reveal no clear pathway to adaptation; revisions may constitute a molehill or a 
mountain according to the responsible body. The merits of theory 2c remain unclear. 
7KHUHVHDUFKUHYLHZHGWKXVIDUH[WHQVLYHDVLWLVWDNHVXVQRIXUWKHUWKDQµSaper 
JXLGHOLQHV¶DQGZHKDYHDOUHDG\KDGFDXVHWRTXHVWLRQWKDWDXWKRULW\The major issue lurking 
ZLWKLQWKHµJORFDOLVP¶SDUDGR[ is, of course, whether locally adapted guidelines improve 
uptake. Do users pay more attention to and act upon guidelines that have been locally 
adapted? Yet another outcrop of studies tackles this problem and we begin a mini-review by 
noting a considerable methodological difficulty. The basic design involves manipulating a 
situation whereby identical groups of practitioners are exposed to existing and to adapted 
versions of the guidelines and then observing differences in their understanding and action. 
Much of the primary literature teaches us that achieving this clean difference will be 
GHPDQGLQJEHFDXVHWKHDFWXDOLW\RIµH[SRVXUH¶WRDJXLGHOLQHLVVRGLYHUVH)RULOOXVWUDWLRQ
we examine findings from two such studies. 
Firstly, we review a cluster trial on guidelines for Stroke Prevention and on Urinary 
Tract Symptoms [65]. Nationally and locally designed guidelines were allocated randomly to 
two divisions of General Practice in Adelaide. The local guidance included additional 
LQIRUPDWLRQUHJDUGLQJDYDLODELOLW\RIGLYLVLRQDOUHVRXUFHVDQGZDVSUHVHQWHGZLWKPRUHµXVHU-
frienGO\¶GHVLJQDQGIRUPDWWLQJ'LVVHPLQDWLRQLGHQWLFDOIRUERWKYHUVLRQVLQFOXGHGPDLOLQJ
shots, newsletter articles, prompt sheets, educational workshops and web-links. Considerable 
FKDQJHLQ*3¶VXVDJHRIJXLGDQFHZDVQRWHG± observable, however, in both arms of the trail. 
7KHDXWKRUVFRQFOXGHµ:KLOVWWKHVWXG\IRXQGVLJQLILFDQWFKDQJHVLQNQRZOHGJHDWWLWXGHV
and reported practice as a result of disseminating guidelines, it did not find any additional 
effect from the local adaptation process. This suggests that the emphasis and investment in 
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promoting guideline implementation should be placed on multifaceted dissemination 
VWUDWHJLHVUDWKHUWKDQORFDODGDSWDWLRQSHUVH¶ [65]. 
A pioneering French study also throws light on the mechanisms through which 
guideline adaptation may work [62]. The background here was the perceived overuse of pre-
operative tests for anaesthetic risk. National guidelines had shown that they were costly, had 
highly restrictive diagnostic use and did not add significantly to the safety of operations. The 
team thus undertook a process of local adaptation of these guidelines at the hospital level (15 
surgical wards). The organisational structures responsible for ordering the tests were mapped 
and team discussions of the new recommendations were set up. Before and after measures 
were taken of referrals for such preoperative tests and in the targeted low-risk groups requests 
fell from 80% to 48%. The question of attribution raises its head; we lack a control group 
here and simply cannot say that the adapted guideline bore responsibility for the change. The 
French team draw a different, system-based lesson. The people responsible for adapting the 
JXLGHOLQHVDUHWKHVDPHSHRSOHZKRRUJDQLVHWKHLPSOHPHQWDWLRQRIWKHQHZJXLGHOLQHVµ:H
think that the main contribution of this work is linking of the process of local adaptation to an 
analysis of the organisational aspects of the practice and the emphasis we placed on the 
RUJDQLVDWLRQDODVSHFWVRIFKDQJH¶ [62]. 
Many other studies of the impact of local adaptation have followed [67,71] but the 
two studies above provide indication of the direction of travel. Whether guideline content is 
de novo or de integro seems to be far less crucial than its passage from the text to consulting 
room, through the conversations between its users, and onto the organisational adaptation 
involved in its usage. In contrast to system strain 1, here we see that theory revision is 
progressive and learning accumulates; over time and with considerable ingenuity this strain 
has proved more tractable. The take-home messages seem to be:  
x Theory 2d ± Adapt guidelines to kindle interest rather than to impart new knowledge.  
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x Theory 2e ± The more local the adaptation the greater the number of interested parties 
who will be drawn directly into implementing and acquiescing with the scheme ± thus 
increasing the chances of them being followed. 
Conclusion 
Further details on attempts to resolve other system strains may be found in the full-
scale review [15]. Here we attempt to draw together the key implications of the above 
analysis, which we separate into three comments ± substantive, methodological and 
procedural. 
1. Given the tumultuous increase in usage, guidelines should be regarded as part of 
the fabric of service delivery rather than as separate interventions with unique objectives. 
When a new guideline is introduced, or when an old one is updated, it will sit alongside a 
range of other organisational controls, rules, norms, customs, practices, targets and 
guidelines. Guidelines will always be constituent part of a system of governance and their 
destiny rests on how well they are absorbed into that system.  
2. There has been an equally tumultuous increase in the research on guidelines and it 
is important to find the appropriate means of synthesising the burgeoning evidence. We have 
demonstrated the limitations of trying to seek a master framework listing all of the factors on 
which success depends. There are scores of barriers and facilitators that help and hinder 
guideline implementation but these do not resolve into some sort of winning formula because 
the factors identified are always interdependent. Dealing with barrier A will always have 
effects, anticipated and unanticipated, on enabler B, and so on. This interconnectivity does 
not leave systematic review with the task of describing unending, unforeseeable change. 
History does repeat itself and a raft of discernible system strains can be detected as guidelines 
are introduced. System change does have a pattern and in the paper we have described a 
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method, realist review that is able to analyse how some of the more familiar strains evolve 
and resolve.  
3. This brings us finally to the business of research utilisation. Evidence is supposed 
to inform policy and practice and this ambition necessitates a realistic understanding of the 
roles of the policy-maker, the manager and the practitioner. Our understanding, in this 
domain, is that the time has long passed for high arbitration about whether or not to have 
guidelines. Decision makers are already awash with guidelines and so they are not sitting, 
Pilate like, awaiting the definitive verdict about their effectiveness. We also presume that 
very few decision-makers work in splendid isolation and have the task of implementing an 
entire guideline system from scratch. They are replete with guidelines and they do not operate 
by ticking off ratified checklists about how they should be managed.  
We do suppose that the key business is system improvement [72] so that patient care 
is optimised.  Accordingly, the crucial task is to dovetail the constant flow of guidelines into 
an existing organisational structure. The really difficult activity is to engineer and re-engineer 
the latest manifestations so they work smoothly with the pre-existing system.  Practitioners 
adjust guidelines to the system and the system to the guidelines. As noted, practitioners 
routinely go about such fine-WXQLQJE\DSURFHVVWKDWKDVFRPHWREHNQRZQDVµPXGGOLQJ
WKURXJK¶[30]. And it is with this reflective process that research synthesis can be most 
helpful. Practitioners can learn by appreciating how their colleagues have struggled with 
similar tensions. If they have available evidence of the relative merits of existing alternatives 
to guideline LQFRUSRUDWLRQWKH\KDYHPDWHULDOVWRKHOSWKHPµWKLQNWKURXJK¶UDWKHUWKDQ
µPXGGOHWKURXJK¶ 
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Table 1: Typological Reviews: Four Accounts of Facilitators and Barriers to Guideline 
Implementation  
Espeland and 
Baerheim (2003) [16] 
Sheldon et al. (2004) 
[19] 
Rashidian et al. 
(2008) [18] 
Lugtenberg et al. 
(2009) [17] 
Knowledge-related 
 
Lack of knowledge of the 
guideline 
 
Attitude/feeling-related 
 
Lack of agreement with 
the guideline:  
- lack of agreement with 
its decision  criteria  
- lack of outcome 
expectancy 
- lack of process 
expectancy 
Lack of feelings 
expectancy 
Lack of self-efficacy 
Lack of motivation/inertia 
of previous practice  
 
External 
 
Guideline-related: unclear 
or impractical to use 
Patient-related pressure  
Setting-related: 
- lack of time  
- lack of other practice 
resources 
- increased costs  
- increased malpractice 
liability  
- external pressures in the 
health care system  
- improper access to 
health care services 
 
Characteristics of 
guidelines  
Strong professional 
support 
Stable and convincing 
evidence base 
No increased or 
unfunded costs 
Good systems for 
tracking guidance 
Professionals involved 
are not isolated 
Guidance clear and 
reflects clinical context 
Characteristics of 
recipients 
Commitment to 
guidance  
Lead clinician identified 
to implement  
Proactive audit of costs 
of implementation  
Responsibility for 
implementation vested 
locally 
Strong clinical 
governance  
Culture of consensus  
Recognise legitimacy of 
provider 
Involvement of 
clinicians in guidelines  
Financial stability  
Expectation that 
compliance in 
mandatory  
Targeted audit of non-
compliance. 
Theme I: credibility of 
content of clinical 
guideline 
Evidence-based  
Flexible 
Theme II: credibility of 
source of clinical 
guideline 
National professional 
bodies  
National governmental 
bodies  
Published in respected 
sources 
Theme III: presentation 
of clinical guidelines 
Simple 
Systematic presentation 
Theme IV: influential 
people in implementation 
Presence of:  Practice 
nurses / primary care team 
/ primary care 
organisations / pharmacists 
/prescribing advisers  
Theme V: organisational 
factors 
Practice characteristics   
Information technology  
Theme VI: disease 
characteristics 
5DUHRUµVLPSOH¶GLVHDVH 
Theme VII: 
dissemination strategy 
Ownership²local vs. 
national guideline  
Perceived need of first 
contact 
Enforced  or supporting 
implementation 
Knowledge 
Lack of knowledge 
Lack of awareness 
familiarity 
Attitude 
Lack of  agreement with 
recommendation 
Lack of applicability 
Lack of outcome 
expectancy 
Lack of motivation 
(practice inertia) 
Behaviour 
~ Patient factors 
3DWLHQWV¶SUHIHUHQFHV
demands 
3DWLHQWV¶DELOLW\
behaviour 
~ Guideline factors 
Unclear / ambiguous 
Incomplete / not up to 
date 
Not easy to use / too 
complex 
~ Environmental factors 
Lack of time / time 
pressure 
Lack of resources / 
materials 
Organisational 
constraints 
Lack of reimbursement  
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Table 2: &RFKUDQHHWDO¶V(2007) [9] µ%DUULHU*URXSLQJV¶ZLWKWKHLUFategories 
(Frequency) 
 
 
 
 
  
Cognitive/behavioral barriers (65) Attitudinal/rational-emotive barriers (58) 
Knowledge (38) Efficacy/perceived competence (16) 
Awareness (13) Perceived/outcome expectancy (16) 
Skill/expertise (9) Confidence in abilities (15) 
Critical appraisal skills (5) Authority (9) 
 Accurate self-assessment (2) 
  
Health care professional/physician 
barriers (62) 
Clinical practice guidelines/evidence 
barriers (41) 
Characteristics (29) Utility (11) 
Age/maturity of practice (11) Evidence/disagree content (11) 
Professional boundaries (7) Access (10) 
Legal issues (5) Structure (5) 
Peer influence, models (5) Local applicability (4) 
Gender (3) Utility (11) 
Inertia (2)  
  
System/process barriers (62) Support/resource barriers (69) 
Organizational (20) Time (31) 
System (17) Support (15) 
HR/workload/overload (10) Costs/funding issues (12) 
Team structure/work (9) Resources (11) 
Referral process (6)  
  
Patient barriers (30)  
Patient characteristics/factors (20)  
Patient adherence (10)  
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Table 3: Gagliardi et al. (2011) [8] Final framework of guideline implementability  
Domain Element Examples 
Usability Navigation Table of contents 
 Evidence format Narrative, tabulated or both 
 
Recommendation 
format 
Narrative, graphic (algorithms) or both; Recommendation summary (single list in full or 
summary version)  
Adaptability Alternate versions Summary (print, electronic for PDA); Patient (tailored for patients/caregivers); Published (journal)  
Validity Number of references Total number of distinct references to evidence upon which recommendations are based 
 Evidence graded A system is used to categorize quality of evidence supporting each recommendation 
 
Number of 
recommendations Total number of distinct recommendations (sub-recommendations considered same) 
Applicability Individualization 
Clinical information (indications, criteria, risk factors, drug dosing) that facilitates application 
of the recommendations explicitly highlighted as tips or practical issues using sub-titles or text 
boxes, or summarized in tables and referred to in recommendations or narrative contextualizing 
recommendations  
Communicability Patient education or involvement 
Informational or educational resources for patients/caregivers, questions for clinicians to 
facilitate discussion, or contact information (phone, fax, email or URL) to acquire informational 
or educational resources  
Accommodation Objective Explicitly stated purpose of guideline (clinical decision making, education, policy, quality improvement)  
 Users 
Who would deliver/enable delivery of recommendations (individuals, teams, departments, 
institutions, managers, policy makers, internal/external agents), who would receive the services 
(patients/caregivers)  
 User needs/values Identification of stakeholder needs, perspectives, interests or values 
 Technical Equipment or technology needed, or the way services should be organized to deliver 
recommendations  
 Regulatory Industrial standards for equipment or technology, or policy regarding their use 
 Human resources Type and number of health professionals needed to deliver recommended services 
 Professional Education, training or competencies needed by clinicians/staff to deliver recommendations 
 Impact Anticipated changes in workflow or processes during/after adoption of recommendations 
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 Costs 
Direct or productivity costs incurred as a result of acquiring resources or training needed to 
accommodate recommendations, or as a result of service reductions during transition from old 
to new processes  
Implementation Barriers/facilitators Individual, organizational, or system barriers that are associated with adoption 
 Tools Instructions, tools or templates to tailor guideline/recommendations for local context; Point-of-
care templates/forms (clinical assessment, standard orders)  
 Strategies Possible mechanisms by which to implement guideline/recommendations 
Evaluation Monitoring 
Suggestions for evaluating compliance with organization, delivery and outcomes of 
recommendations, including program evaluation, audit tools, and performance measures/quality 
indicators  
